Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease

Ha E Lee^{1

2}, Dami Lim^{1

3}, Jae Y Lee³, Sang M Lim^{1

2}, Ae N Pae^{1

2

3}

Affiliations

¹ Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology, Seoul 02792, Republic of Korea.
² Division of Bio-Medical Science & Technology, KIST School, Korea University of Science & Technology, Seoul 02792, Republic of Korea.
³ KHU-KIST Department of Converging Science & Technology, Kyung Hee University, Seoul 02447, Republic of Korea.

Editorial

Ha E Lee et al. Future Med Chem. 2019 Aug.

. 2019 Aug;11(15):1845-1848.

doi: 10.4155/fmc-2019-0151.

Ha E Lee^{1

2}, Dami Lim^{1

3}, Jae Y Lee³, Sang M Lim^{1

2}, Ae N Pae^{1

2

3}

¹ Convergence Research Center for Diagnosis, Treatment & Care System of Dementia, Korea Institute of Science & Technology, Seoul 02792, Republic of Korea.
² Division of Bio-Medical Science & Technology, KIST School, Korea University of Science & Technology, Seoul 02792, Republic of Korea.
³ KHU-KIST Department of Converging Science & Technology, Kyung Hee University, Seoul 02447, Republic of Korea.

No abstract available

Keywords: Alzheimer's disease; acetylation; aggregation; deglycosylation; immunotherapy; tau.

Publication types